Skip to main content

. 1986 May;53(5):697–699. doi: 10.1038/bjc.1986.116

The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.

N A Habib, M J Hershman, F Haberland, L Papp, C B Wood, R C Williamson

PMCID: PMC2001389 PMID: 3459510

697

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Gordis L., Gold E. B. Epidemiology of pancreatic cancer. World J Surg. 1984 Dec;8(6):808–821. doi: 10.1007/BF01656020. [DOI] [PubMed] [Google Scholar]
Holmgren J., Lindholm L., Persson B., Lagergård T., Nilsson O., Svennerholm L., Rudenstam C. M., Unsgaard B., Yngvason F., Pettersson S. Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. Br Med J (Clin Res Ed) 1984 May 19;288(6429):1479–1482. doi: 10.1136/bmj.288.6429.1479. [DOI] [PMC free article] [PubMed] [Google Scholar]
Krain L. S. The rising incidence of carcinoma of the pancreas--real or apparent? J Surg Oncol. 1970;2(2):115–124. doi: 10.1002/jso.2930020206. [DOI] [PubMed] [Google Scholar]
Lindholm L., Holmgren J., Svennerholm L., Fredman P., Nilsson O., Persson B., Myrvold H., Lagergård T. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol. 1983;71(2):178–181. doi: 10.1159/000233384. [DOI] [PubMed] [Google Scholar]
Malagelada J. R. Pancreatic cancer: an overview of epidemiology, clinical presentation, and diagnosis. Mayo Clin Proc. 1979 Jul;54(7):459–467. [PubMed] [Google Scholar]
Morgan R. G., Wormsley K. G. Progress report. Cancer of the pancreas. Gut. 1977 Jul;18(7):580–596. doi: 10.1136/gut.18.7.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
Zamcheck N. The present status of carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis and evaluation of therapy of colonic and pancreatic cancer. Clin Gastroenterol. 1976 Sep;5(3):625–638. [PubMed] [Google Scholar]

ACTIONS

RESOURCES